Join us for dinner and learn about HEMGENIX: the first and only FDA-approved gene therapy for hemophilia B. HEMGENIX is a onetime gene therapy for treatment of adults with hemophilia B who currently use Factor IX prophylaxis therapy or have current or historical life-threatening bleeding or have repeated, serious spontaneous bleeding episodes. If you have hemophilia B or have someone in your family with hemophilia B, this is a great opportunity to learn more about HEMGENIX.

Event Speaker:
Guy Young, MD
Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Children’s Hospital Los Angeles
Professor of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, California

Dr. Guy Young is the Director of the Hemostasis and Thrombosis Center and the Clinical Coagulation Laboratory at Children’s Hospital Los Angeles and a Professor of Pediatrics at the University of Southern California Keck School of Medicine. He received his medical degree from the State University of New York at Stony Brook School of Medicine and completed a fellowship in pediatric hematology/oncology at Children’s National Medical Center, which is part of George Washington University School of Medicine in Washington, DC. Dr. Young has published many journal articles, abstracts, and textbook chapters and has delivered lectures, workshops, and presentations at national and international meetings. He is the former chair of the Scientific and Standardization Committee on Factor VIII, Factor IX, and Rare Bleeding Disorders of the International Society on Thrombosis and Haemostasis and was awarded the National Hemophilia Foundation Physician of the Year Award in 2013.

Program Information:
Date: Thursday, March 31, 2023
Time: 5:45 PM – 7:30 PM

Spinato’s Pizzeria and Family Kitchen, 5509 N. 7th Street, Phoenix, AZ 85014


Presented By: